{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Year in Review: Top U.S. Biosimilars-Related Regulatory Developments of 2020",
"url": "https://www.lexblog.com/2020/12/29/year-in-review-top-u-s-biosimilars-related-regulatory-developments-of-2020/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-75XSDWR6",
"url": "https://www.lexblog.com/lib/75XSDWR6/"
},
"datePublished": "2020-12-29T15:23:12-05:00",
"dateModified": "2020-12-29T16:12:06-05:00",
"author": {
"@type": "Person",
"name": "Big Molecule Watch"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Goodwin Procter"
},
"organizationScope": "at-publication",
"isPartOf": "Big Molecule Watch",
"about": "Administrative and Regulatory ยท Health Care and Life Sciences",
"sourceUrl": "https://www.bigmoleculewatch.com/2020/12/29/year-in-review-top-u-s-biosimilars-related-regulatory-developments-of-2020/",
"sourceStability": "may-move"
}